Release of plasminogen activator inhibitor-1 from human astrocytes is regulated by intracellular ceramide

Journal of Neuroscience Research

Volumn 62, Issue 6, 2000, Pages 781-788

  Kimura, Masahiko ^a   Soeda, Shinji ^a   Oda, Masatoshi ^a   Ochiai, Takashi ^a   Kihara, Taro ^a   Ono, Nobufumi ^a   Shimeno, Hiroshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Astrocytes; Ceramide; Neuronal cell death; Plasminogen activator inhibitor 1; Tumor necrosis factor

Indexed keywords

CERAMIDE; DAUNORUBICIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SPHINGOMYELIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DEATH; CELL LEVEL; CELL MEMBRANE PERMEABILITY; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASTROCYTES; CELL DEATH; CERAMIDES; CULTURE MEDIA, CONDITIONED; DAUNORUBICIN; ENZYME INHIBITORS; HUMANS; NEURONS; PC12 CELLS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; SPHINGOSINE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034672316     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20001215)62:6<781::AID-JNR4>3.0.CO;2-W     Document Type: Article

References (30)

1. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generation death signals
2. Molecular profile of reactive astrocytes
3. Ceramide induces apoptosis in PC12 cells
4. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons: Implications for the regulation of motor learning and neuronal survival
5. Differential mechanism targeting type 1 plasminogen activator inhibitor and vitronectin into the strage granules of a human megakaryocytic cell line
6. The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver
7. Application of exogenous ceramide to cultured rat spinal motoneurons promotes survival or death by regulation of apoptosis depending on its concentrations
8. Ceramide prevents motoneuronal cell death through inhibition of oxidative signal
9. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation
10. Daunorubicin-induced apoptosis: Triggering of ceranude generation through sphingomyelin hydrolysis
11. Impaired neuroglial activation in interleukin-6 deficient mice
12. Sphingolipid metabolism in the regulation of bioactive molecules
13. Subcellular localization and membrane topology of serine palnutoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver
14. Ceramide: A novel second messenger
15. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β
16. An update of the enzymology and regulation of sphingomyelin metabolism
17. Programmed cell death induced by ceramide
18. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin
19. Low nanogram range quantitation of diglycerides and ceramide by high-performance liquid chromatography
20. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation
21. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning
22. 2-ceramide may be responsible for its ability to inhibit platelet aggregation
23. Tumor necrosis factor-α-induced release of plasminogen activator inhibitor-1 from human umbilical vein endothelial cells: Involvement of intracellular ceramide signaling event
24. Ceramide synthesis and sphingomyelin hydrolysis in bovine liver microsomes: Development of assay method and application to their characterization
25. Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro
26. Excitotoxin-induced neuronal degradation and seizure are mediated by tissue plasminogen activator
27. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo
28. Inhibition of sphingolipid biosynthesis by fumonisins: Implications for diseases associated with Fusarium moniliforme
29. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide-induced cerebral endothelial cell death
30. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death: Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation